These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35230971)

  • 1. Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B.
    Kumar D; Kashyap MK; Yu Z; Spaanderman I; Villa R; Kipps TJ; La Clair JJ; Burkart MD; Castro JE
    Aging (Albany NY); 2022 Mar; 14(5):2081-2100. PubMed ID: 35230971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.
    Kashyap MK; Kumar D; Villa R; La Clair JJ; Benner C; Sasik R; Jones H; Ghia EM; Rassenti LZ; Kipps TJ; Burkart MD; Castro JE
    Haematologica; 2015 Jul; 100(7):945-54. PubMed ID: 25862704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells.
    Anufrieva KS; Shender VО; Arapidi GP; Pavlyukov MS; Shakhparonov MI; Shnaider PV; Butenko IO; Lagarkova MA; Govorun VM
    Genome Med; 2018 Jun; 10(1):49. PubMed ID: 29950180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction and cell cycle arrest of pladienolide B in erythroleukemia cell lines.
    Jorge J; Petronilho S; Alves R; Coucelo M; Gonçalves AC; Nascimento Costa JM; Sarmento-Ribeiro AB
    Invest New Drugs; 2020 Apr; 38(2):369-377. PubMed ID: 31147807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells.
    Zhang Q; Di C; Yan J; Wang F; Qu T; Wang Y; Chen Y; Zhang X; Liu Y; Yang H; Zhang H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1273-1280. PubMed ID: 30963795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High antitumor activity of pladienolide B and its derivative in gastric cancer.
    Sato M; Muguruma N; Nakagawa T; Okamoto K; Kimura T; Kitamura S; Yano H; Sannomiya K; Goji T; Miyamoto H; Okahisa T; Mikasa H; Wada S; Iwata M; Takayama T
    Cancer Sci; 2014 Jan; 105(1):110-6. PubMed ID: 24635824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds.
    Cretu C; Agrawal AA; Cook A; Will CL; Fekkes P; Smith PG; Lührmann R; Larsen N; Buonamici S; Pena V
    Mol Cell; 2018 Apr; 70(2):265-273.e8. PubMed ID: 29656923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splicing factor SF3b as a target of the antitumor natural product pladienolide.
    Kotake Y; Sagane K; Owa T; Mimori-Kiyosue Y; Shimizu H; Uesugi M; Ishihama Y; Iwata M; Mizui Y
    Nat Chem Biol; 2007 Sep; 3(9):570-5. PubMed ID: 17643112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.
    Sciarrillo R; Wojtuszkiewicz A; El Hassouni B; Funel N; Gandellini P; Lagerweij T; Buonamici S; Blijlevens M; Zeeuw van der Laan EA; Zaffaroni N; Deraco M; Kusamura S; Würdinger T; Peters GJ; Molthoff CFM; Jansen G; Kaspers GJL; Cloos J; Giovannetti E
    EBioMedicine; 2019 Jan; 39():215-225. PubMed ID: 30581150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of RNA Splicing in Regulation of Cancer Stem Cell.
    Tripathi G; Tripathi A; Johnson J; Kashyap MK
    Curr Stem Cell Res Ther; 2023; 18(1):3-6. PubMed ID: 34875992
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological validation that SF3b is a target of the antitumor macrolide pladienolide.
    Yokoi A; Kotake Y; Takahashi K; Kadowaki T; Matsumoto Y; Minoshima Y; Sugi NH; Sagane K; Hamaguchi M; Iwata M; Mizui Y
    FEBS J; 2011 Dec; 278(24):4870-80. PubMed ID: 21981285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer.
    Naro C; Antonioni A; Medici V; Caggiano C; Jolly A; de la Grange P; Bielli P; Paronetto MP; Sette C
    J Exp Clin Cancer Res; 2024 Feb; 43(1):58. PubMed ID: 38413979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilized cyclopropane analogs of the splicing inhibitor FD-895.
    Villa R; Kashyap MK; Kumar D; Kipps TJ; Castro JE; La Clair JJ; Burkart MD
    J Med Chem; 2013 Sep; 56(17):6576-82. PubMed ID: 23919277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-mRNA splicing repression triggers abiotic stress signaling in plants.
    Ling Y; Alshareef S; Butt H; Lozano-Juste J; Li L; Galal AA; Moustafa A; Momin AA; Tashkandi M; Richardson DN; Fujii H; Arold S; Rodriguez PL; Duque P; Mahfouz MM
    Plant J; 2017 Jan; 89(2):291-309. PubMed ID: 27664942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia.
    Kashyap MK; Karathia H; Kumar D; Vera Alvarez R; Forero-Forero JV; Moreno E; Lujan JV; Amaya-Chanaga CI; Vidal NM; Yu Z; Ghia EM; Lengerke-Diaz PA; Achinko D; Choi MY; Rassenti LZ; Mariño-Ramírez L; Mount SM; Hannenhalli S; Kipps TJ; Castro JE
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102202. PubMed ID: 38846999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
    Zhang Y; Yuan Z; Jiang Y; Shen R; Gu M; Xu W; Gu X
    Med Sci Monit; 2020 Jan; 26():e919460. PubMed ID: 31927557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.
    Effenberger KA; Anderson DD; Bray WM; Prichard BE; Ma N; Adams MS; Ghosh AK; Jurica MS
    J Biol Chem; 2014 Jan; 289(4):1938-47. PubMed ID: 24302718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
    Alors-Perez E; Blázquez-Encinas R; Alcalá S; Viyuela-García C; Pedraza-Arevalo S; Herrero-Aguayo V; Jiménez-Vacas JM; Mafficini A; Sánchez-Frías ME; Cano MT; Abollo-Jiménez F; Marín-Sanz JA; Cabezas-Sainz P; Lawlor RT; Luchini C; Sánchez L; Sánchez-Hidalgo JM; Ventura S; Martin-Hijano L; Gahete MD; Scarpa A; Arjona-Sánchez Á; Ibáñez-Costa A; Sainz B; Luque RM; Castaño JP
    J Exp Clin Cancer Res; 2021 Dec; 40(1):382. PubMed ID: 34857016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Inhibition of Pre-mRNA Splicing in Living Saccharomyces cerevisiae.
    Hansen SR; Nikolai BJ; Spreacker PJ; Carrocci TJ; Hoskins AA
    Cell Chem Biol; 2019 Mar; 26(3):443-448.e3. PubMed ID: 30639260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity.
    Kim Guisbert KS; Guisbert E
    PLoS One; 2017; 12(4):e0176382. PubMed ID: 28445500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.